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ABSTRACT 
Successful sexual act is one of the most basic needs for the production of the future generations. Successful 
sexual act is not possible, if a person is suffering from the Klaibya. Acharya have mentioned different 
causes of the Klabiya, and Malanashishinta is one among these. Malanshishinta can be compared with the 
erectile dysfunction on the basis of symptoms.  
The Sthiradipanchamooladi Yapana Basti (960ml/day for 16days), which is mentioned in the Caraka 
Samhita for Vajikarana by Caraka and Vanari Gutika (5gm twice daily was given P.O. with milk as Anupana 
for 30 days) mentioned by Bhavaparkasha in Vajikarana chapter are used in this study. One of the basic 
aims of this thesis is to evaluate, whether the drugs administered through Basti have any benefit over the 
drugs administered orally, particularly in reference to the administration of Vajikarana drugs for the 
treatment. Total 30 patients were selected from the OPD & IPD in the P.G.Department of Panchakarma at 
National Institute of Ayurveda Jaipur, Rajasthan. The patients were randomly divided into three groups 
and named as Group A, Group B and Group C, with 10 patients in each group. Highly significant result was 
found in overall effect the subjective criteria in the group of A, B and group C with 55.55%, 34.78% and 
94.44% respectively. In the semen analysis highly significant result was found in group-c with 42.34 % 
(semen volume), 15.97 % (Sperm count) and in Immotile sperm 45.01% respectively. 
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INTRODUCTION 
 The Ayurveda is a science that deals with the 
human life. The first priority of Ayurveda is the prevention 
of disease and maintaining the health of a healthy 
individual[1]. So, a man should follow such a dietary and 
daily regime, which will maintain his good health and 
prevent any illness in future[2]. Ayurveda defines an ideal 
man as one who has got a healthy body, mind and Indriya, 
and leads such a life which is congenial to his personal 
development and conducive to social happiness. Acharya 
Vagbhatta has described the tripod of life as Aahara, Nidra, 
and Abrahamcharya. By the mention of Abrahmcharya, the 
Acharya gives a clear cut importance to sexual functions in 
human life. 
  The Veda divided human life into four stages i.e., 
Brahmacharya, Grahstha, Vanprastha, and Sanyasa 
Asharama. Through these stages a human being achieves 
Dharma, Artha, Kama, and finally Moksha, which is the 
ultimate goal of human life. Acharya Susruta has written a 
separate chapter, “Shukrashonita Shudhi Adhyya”, in which 
he has given complete description of “Shudha Shukra”, 
Shudha Shonita”, causes of deformities, and complete 
management. The aim of the chapter seems to be the 
production of Shudha Shukra, Shudh Shonita, so that, 
healthy human progeny is produced. Acharya Caraka has 
also mentioned in detail, “Shudha Shukra,” Shudha 
Shonita”, treatment of their diseases. Caraka has written a 
separate chapter on Vajikarna, and mentions that by 
following the rules and regulations of Vajikarna one can 
achieve healthy progeny. By achieving good progeny one 
achieves Dharma, Artha, Preeti and Yasha[3]. Good progeny 
benefits a person even in Vanprastha and Sanyasa Ashram. 
Successful sexual act is one of the most basic needs for the 
production of the future generations. Successful sexual act 
is not possible, if a person is suffering from the Klaibya. 
Acharya have mentioned different causes of the Klabiya, 
and Malanashishinta is one among these. Malanshishinta 
can be compared with the erectile dysfunction on the basis 
of symptoms. Due to the Klaibya a person is not able to 
produce offspring's. When a person is not able to complete 
his family, he is labelled with a social stigma. This becomes 
a reason for his physical, mental and social disturbance.   
 WHO defines the sexual dysfunction as “the various 
ways in which an individual is unable to participate in a 
sexual relationship as he or she would wish”. The male 
sexual dysfunction includes all sorts of disturbances of 
coital performance and sexual congress in male. Male 
sexual dysfunction or “impotence” can be defined as a 
“man’s inability to attain or maintain an erection of 
sufficient strength to perform the act of intercourse”. 
  Oral pharmacotherapy represents the first line 
option for most of the patients with erectile dysfunction. 
Sildenafil and Apomorphine are presently used for erectile 
dysfunction in modern medicine. Patients who do not 
respond to oral pharmacotherapy or who cannot use it are 
good candidates for intracavernosal and intraurtheral 
therapy. Alprostadil is the most widely used drug both for 
injection therapy and for the intraurtheral route. It is 
estimated that currently 25–30 million men worldwide 
taking PDE5 inhibitors, and an additional 50 million or 
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more who are potential candidates for treatment. Now it is 
clear, that there are so many adverse effects of PDE5 
inhibitors and no satisfactory result even after long time 
use. Nowadays, a famous medicine for erectile dysfunction 
is sildenafil, but it has negative side effects for 
cardiovascular system. Although, there are many drugs 
available for the treatment of the erectile dysfunction in 
allopathy but they have many serious adverse effects and 
are very costly.  
 Due to these reasons, the Ayurvediya system of 
medicine must play its role for the management of erectile 
dysfunction without lethal side effects. So, the aim of the 
study is to manage the erectile dysfunction by using chief, 
easily available and safe Ayurvediya medicines. The 
Sthiradipanchamooladi Yapana Basti which is mentioned 
in the Caraka Samhita for Vajikarana by Caraka and Vanari 
Gutika mentioned by Bhavaparkasha in Vajikarana chapter 
are used in this study. One of the basic aims of this thesis is 
to evaluate, whether the drugs administered through Basti 
have any benefit over the drugs administered orally, 
particularly in reference to the administration of 
Vajikarana drugs for the treatment. 
Aims and Objectives 
The present research trial has been undertaken with the 
following aims and objectives. 
1. To conceptualize and evaluate the approach of 
Ayurvediya management in the Klaibya w.s.r. to erectile 
dysfunction. 
2. To study the efficacy of the Vanari Gutika and the 
Sthiradipanchamula Yapana Basti in the management of 
the Klaibya. 
3. To compare the efficacy of Vanari Gutika and the 
Sthiradipanchamula Yapana Basti on the Klaibya, when 
administrated separately and when given in the 
combination. 
Materials and Methods 
The following material and method were adopted for 
conducting the clinical trials.  
Selection of Cases 
Total 30 patients were selected from the OPD & IPD in 
the P.G.Department of Panchakarma at National 
Institute of Ayurveda Jaipur, Rajasthan.  
Inclusion Criteria 
o Adult male patients who were married and were b/w 
the age of 21 to 60 years.  
o Patients having signs and symptoms of the Klaibya 
according to Ayurveda and Modern texts.  
Exclusion Criteria 
o Disorder in sexual organs e.g. hypospadias, epispadias 
etc.  
o Unmarried Patients.  
o Patients with diseases like severe Hypertension, 
Diabetes mellitus, IHD, COPD, Liver cirrhosis etc.  
o Patients with sexually transmitted diseases.  
o Erectile dysfunction due to nerve damage e.g. 
Accidental injury like spinal cord injury.  
o Erectile dysfunction due to surgical cause e.g. surgery 
of colon, prostate, urinary bladder, rectum etc. 
Study design and Grouping  
This study was an open label, randomized, comparative, 
interventional study using pre-test and post-test design. 
After inclusion, the patients were randomly divided into 
three groups and named as Group A, Group B and Group C, 
with 10 patients in each group. 
Selection of Drugs: In the present study, Yapana Basti 
was selected for one group. The Vanari Gutika was selected 
for the second group, and in third group both Vanari 
Gutika and Yapana Basti were administered 
simultaneously.  
Groupings 
Group-A: In this group Sthiradipanchamoola Yapana Basti 
was given approx. 960ml/day for 16days. 
Group-B: In this group “Vanari Gutika” 5gm twice daily 
was given P.O. with milk as Anupana for 30 days. 
Group-C: In this group, Sthiradipanchamoola Yapana Basti 
was given for 16 days, and “Vanari Gutika” as 5gm twice 
daily P.O. with milk as Anupana for 30 days. 
Criteria for Assessment: Both subjective & objective 
parameters were employed for assessment of the impact 
of the treatment. 
Subjective parameters: - The following signs and 
symptoms of Klaibya were assessed before and after the 
course of therapy.  
1. Mlanashishnata[4] 
Clinical Interpretation of Mlanashishnata 
 Assessment of signs and symptoms was done pre 
and post trial on severity grading scale developed by Dr. 
Sriniwas sharma et.al. 
0 1 2 3 4 5 
0- No erection at all 
1- Erection but not Sustained 
2- Sustained Erection 
3- Erection but not enough for penetration 
4-  Erection Enough for penetration 
5- Successful intercourse  
 2. Efficacy Assessment of Parameters of Selected 
Drugs.  
A) International Index of Erectile Function 15 items 
(IIEF-15) 
 These questions were asked about the effects that 
the erection problems have had on patient’s sex life over 
the past 4 weeks:  
Questionnaire:  
Q.1. How often was you able to get an erection during 
sexual activity?  
0- No sexual activity  
1-Almost never or never  
2-A few times (less than half the time)  
3-Sometimes (about half the time)  
4-Most times (more than half the time)  
5-Almost always or always  
Q.2. When you had erections with sexual stimulation, 
how often were your erections hard enough for 
penetration?  
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0-No sexual activity  
1-Almost never or never  
2-A few times (less than half the time)  
3-Sometimes (about half the time)  
4-Most times (more than half the time)  
5-Almost always or always  
Q.3. When you attempted intercourse, how often were 
you able to penetrate  
(Enter) your partner?  
0-Did not attempt intercourse  
1-Almost never or never  
2-A few times (less than half the time)  
3-Sometimes (about half the time)  
4-Most times (more than half the time)  
5-Almost always or always  
Q.4.During sexual intercourse, how often were you 
able to maintain your erection after you had 
penetrated (entered) your partner?  
0-Did not attempt intercourse  
1-Almost never or never  
2-A few times (less than half the time)  
3-Sometimes (about half the time)  
4-Most times (more than half the time)  
5-Almost always or always  
Q.5.During sexual intercourse, how difficult was it to 
maintain your erection to completion of intercourse?  
1-Did not attempt intercourse  
2-Extremely difficult  
3-Very difficult  
4-Difficult  
5-Slightly difficult88  
6-Not difficult 
Q.15.How do you rate your confidence that you could 
get and keep an erection?  
1-Very low, 2-Low, 3-Moderate, 4-High, 5-Very high  
Scoring Algorithm for IIEF: All items are scored in 5 
domains as follows:  
Items Domain (questions) Range Max Score 
Erectile 
Function 
1, 2, 3, 4, 5, 15 0-5 30 
Clinical Interpretation of IIEF 5 
Erectile function total scores can be interpreted as 
follows:  
0-6 - Severe dysfunction. 
7-12 - Moderate dysfunctions 
13-18 - Mild to moderate dysfunction 
19-24 - Mild dysfunctions 
25-30 - No dysfunction 
Objective parameters (semen analysis) 
The analysis was carried out to assess the effect of the 
therapy before and after the treatment in the patients. 
 
 
Statistical Analysis 
 In Stat Graph Pad 3 software was used & for non-
parametric Data Wilcoxon matched-pairs signed ranks test 
was used while for Parametric Data Paired ‘t’ Test was 
used and the results were calculated in each group. For 
calculating the Inter group comparison, KRUSKALWALLIS 
& ANOVA Test was used and results calculated. 
 Insignificant: P >0.05,  
 Significant: P <0.05 
 Highly significant: P < 0.01, P < 0.001, P<0.0001 
Results 
 All the 30 subjects registered under all the three 
groups completed the course of the treatment for 30 days 
and follow up for 60 days. The effect of the therapy on 
different parameters like International Index of Erectile 
Function (IIEF) scoring, Mlanashishnata were assessed 
after the complete course of the treatment and follow up. 
The results obtained, before and after the treatments were 
analyzed by using Software: In Stat  
Graph Pad 3. 
A) Effect of The therapy on the subjective parameter  
1. Effect of the therapy on IIEF Q: 1  
In Group A, Group B and Group C a relief of 92.31%, 
91.66% and 90% was noted respectively, which is 
statistically significant (p<0.05) in all the three groups.  
2. Effect of the therapy on IIEF Q: 2  
In Group A, Group B and Group C a relief of 80%, 76.92% 
and 93.75% was noted respectively, which is statistically 
significant (p<0.05) in all the three groups.  
3. Effect of the therapy on IIEF Q: 3  
In Group A, Group B and Group C a relief of 52.94%, 
56.25% and 94.11% was noted respectively, which is 
statistically significant (p<0.05) in all the three groups.  
4. Effect of the therapy on IIEF Q: 4   
In Group A, Group B and Group C a relief of 75%, 73.33% 
and 91.66% was noted respectively, which is statistically 
significant (p<0.05) in all the three groups.  
5. Effect of the therapy on IIEF Q: 5  
In Group A, Group B and Group C a relief of 42.85%, 36% 
and 93.75% was noted respectively, which is statistically 
significant (p<0.05) in all the three groups.  
6. Effect of the therapy on IIEF Q: 15  
In Group A, Group B and Group C a relief of 55.55%, 
34.78% and 94.44% was noted respectively, which is 
statistically significant (p<0.05) in all the three groups.  
7. Effect of the therapy on Mlanashishnata 
In Group A, Group B and Group C a relief of 55%, 45% 
and 92.85% was noted respectively, which is statistically 
significant (p<0.05) in all the three groups.  
B) Effect of the therapy on the objective parameter  
1. Effect of the treatment on Semen volume 
In Group A, Group B and Group C an improvement of 
35.75%, 28.76% and 42.34% was noted respectively, 
which is statistically significant (P<0.05), significant 
(p<0.05) and highly significant (P<0.0001) respectively in 
the three groups.  
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2. Effect of the treatment on Semen pH 
In Group A, Group B and Group C an improvement of 
01.61%, 0.39% and 4.80% was noted respectively, which 
is statistically significant (p<0.05), non-Significant 
(P>0.05) and significant (p<0.05) respectively in the three 
groups. 
3. Effect of the treatment on sperm count 
 In Group A, Group B and Group C an improvement of 
12.30%, 8.14% and 15.97 % was noted respectively, which 
is statistically significant (P<0.05), significant (p<0.05) and 
highly significant (P<0.0001) respectively in the three 
groups.  
4. Effect of the treatment on Rapid Linear Progression 
of sperm 
In Group A, Group B and Group C an improvement of 
26.17%, 19.31% and 30.88% was noted respectively, 
which is statistically highly significant (P<0.0001), highly 
significant (P<0.0001) and highly significant (P<0.0001) 
respectively in the three groups.  
 
 
5. Effect of the treatment on Sulggish Linear 
Progression of sperm: 
 
 In Group A, Group B and Group C an improvement of 
18.14%, 15.85% and 19.22% was noted respectively, 
which is statistically highly significant (P<0.0001), highly 
significant (P<0.0001) and highly significant (P<0.0001) 
respectively in the three groups.  
 6. Effect of the treatment on Non Progression of 
sperm: 
In Group A, Group B and Group C an improvement of 
20.58%, 20.70% and 34.19% was noted respectively, 
which is statistically significant (P<0.05), significant 
(p<0.05) and highly significant (P<0.0001) respectively in 
the three groups.  
7. Effect of the treatment on immotile sperm: 
In Group A, Group B and Group C an improvement of 
40.90%, 38.44% and 45.01% was noted respectively, 
which is statistically highly significant (P<0.0001), highly 
significant (P<0.0001) and highly significant (P<0.0001) 
respectively in the three groups.  
Table 4: Inter group comparison between Group A, Group B and Group C 
Variables Group A Group B Group C P Value Remark 
IIEF Q:1 1.2 1.1 0.9 0.0465 S 
IIEF Q:2 1.2 1 1.5 0.6485 NS 
IIEF Q:3 0.9 0.9 1.6 0.0654 NS 
IIEF Q:4 1.2 1.1 1.1 0.321 NS 
IIEF Q:5 0.9 0.9 1.5 0.047 S 
IIEF Q:15 1 0.8 1.7 0.422 NS 
Mlanashishnata 1.1 0.9 1.3 0.8764 NS 
(HS: Highly Significant S: Significant NS: Non Significant) 
Graph 1: Inter group comparison between Group A, Group B and Group C 
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Table 8: Inter group comparison between Group A, Group B and Group C for objective parameters (semen 
analysis) 
Variables 
Group A 
Mean (AT) 
Group B 
Mean (AT) 
Group C 
Mean( AT) P value  Remark 
Semen volume 0.64 0.53 0.77 0.1717 NS 
Semen pH 0.105 0.025 0.309 0.0039 S 
Sperm Count 5.796 3.906 7.65 0.1241 NS 
RLP 11.91 9.21 13.87 0.1045 NS 
SLP 5.819 4.724 6.245 0.4366 NS 
NP 2.247 2.367 3.59 0.5133 NS 
IM 4.27 3.972 4.61 0.4511 NS 
(RLP- Rapid linear progressive, SLP- Sluggish linear progress, NP- non progressive, IM-Immotile sperm) 
Graph 2: Inter group comparison between Group A, Group B and Group C for objective parameters (semen 
analysis) 
 
 
 
 
 
DISCUSSION 
 Ayurvediya Acharya Caraka has placed the Kama 
as one among the cardinal factors of Purushartha. This 
shows the importance they have attributed to Kama. The 
other three factors include Dharma (virtuous action), 
Artha (wealth), and Moksha (salvation). The Kama means 
Sukha it is attained by the virtuous actions and by making 
good use of the wealth. Even though the Kama is having a 
broad meaning, in the present study it is used to mention 
the sexual desire. It comprises many other factors 
including the normal functioning of behavior, social, 
psychological and physiological factors. In a sexual act, 
even though male plays leading role, female too have to 
perform her role properly. As sexual union is not an 
individual entity, the partners have equal responsibility in 
the successful completion of the intercourse; they are 
assigned with duties to have pleasure and satisfaction. Any 
dissatisfaction between the partners in successful sex 
causes a strong unpleasant attitude towards each other 
and is the root-cause of many family conflicts, divorces and 
even suicides. 
 Successful sexual-life is the result of the balance of 
Sharirik and Mansik Dosha. Vata is the prime reason for 
vitiation of other Dosha. Yapana Basti balances the Vata, 
and is Balya, Shukramasvardhak, and Sarvaroga-
prashamana. Shukra has a dual function, not only 
producing the sperm but also Ojas, the finest product of 
digestion. Ojas creates vigor, bliss, lightness, stamina, 
immunity, luster in the skin, and sparkle in the eyes, and 
clarity of mind. Ojas is vital to the health and happiness of 
everyone. Anyone who wants mental clarity, immunity, 
and spiritual well-being will find these recommendations 
useful, because it enhances the Shukra dhatu and thus 
enhance Ojas." These properties result in good health, 
good quality of Shukra Dhatu, and hence prove beneficial 
in Klaibya.  
 Bavaparkasha claims that Vanari Gutika is most 
superior medicine among all the Vajikarana Ausadha for 
Linga shaithilaya. Kapikacchu is the main ingredient 
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having Madhura Rasa, Madhura Vipaka and Guru Guna. 
These properties make it Dhatu Pushtikaraka[5]. Kapikachu 
is well known for its aphrodisiac action. In addition, it is 
having mood elevating property too. Kapikachu is a good 
source of dopamine[6]. More specific to sexual function, it is 
likely that dopamine triggers penile erection. The other 
constituents i.e., Dugdha, Sharkra, Madhu, Gogrith are 
mainly Balya and contribute towards good health. By, 
these qualities Vanari Gutika proves very beneficial in the 
management of the Klaibya.  
 Probable Mode of Action of the Therapy 
A) Discussion on Sthiradipanchamoola yapana Basti 
Vata is a very important Dosha to be managed 
during the treatment of any disease, as Acharya told that 
other Dosha are handicapped without Vata Dosha[7], & 
Basti is the prime therapy in the management of Vata 
Dosha, & is called as Ardhachikitsa in any sort of disease, as 
mentioned in Carak Siddhisthana[8]. Also, Sushruta in 
Cikitsasthana chapter 35 mentioned not only in Vata 
Dosha, but Pittaja, Kaphaja, Raktaja, Sansarga, Sannipatika 
conditions can be benefited by Basti. Acharya Sushruta 
compared Doshnirharana potential of Basti with the Sun. 
He told that Basti has the potential to excrete morbid 
Dosha from all the parts of the body even though it is 
Pakvashayastha, in the same way that the Sun has potential 
to suck all the Rasa in Prithvi, even though it resides in 
Aakash[9]. 
Discussion on Vanari Gutika  
 Although a number of medicines are described in 
classical literatures of Ayurveda, we have selected one 
recipe called Vanari Gutika from Bavaparkasha. 
Kapikacchu is having Dhatu Pushtikaraka. Kapikachu is 
well known for its aphrodisiac action. In addition, 
Kapikachu is a good source of dopamine. More specific to 
sexual function, it is likely that dopamine can trigger penile 
erection, by acting on neurons located in the para-
ventricular nucleus of the hypothalamus, and perhaps on 
the pro-erectile sacral parasympathetic nucleus within the 
spinal cord. So, central dopamine is a key neuro-
transmitter in the control of sexual function[10]. Dugdha is 
well known aphrodisiac and life stabilizer drug. Being 
Rasayana, Dugdha improves the quality of Dhatu produced 
and also brings the Dushti of Dhatu (Dusya) to a normal 
state. Ghrita with its Sheeta Virya and Rasayana properties 
helps in improving all the Dhatu. Ghrita is proved to be 
beneficial for aphrodisiac purpose and delays the ageing. 
Sharkra is Madhura in Rasa, Balya, Daha Nashak and 
Shukrala. So it is useful in increasing the stamina and 
therefore helps in the management of the Klaibya. 
 
 
 
CONCLUSION 
 The conclusion is the final outcome of any 
scientific study. The Klaibya is a disease which affects ones 
normal life to a great extent by making cracks in the 
relation of partners and there by disturbing the peace of 
mind of both the partners. The Klaibya is one of the basic 
reasons for divorces and suicides among married partners. 
The Klaibya is a disease which affects ones normal life to a 
great extent by making cracks in the relation of partners 
and there by disturbing the peace of mind of both the 
partners. The Klaibya is one of the basic reasons for 
divorces and suicides among married partners. 
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